Skip to main content
Back
Watch Compare

INTELLIGENT BIO SOLUTIONS INC.

Data quality: 100%
INBS
NASDAQ Manufacturing Measuring & Analyzing Instruments
$2.78
▲ $0.05 (1.68%)
6 months return
—
Momentum
Neutral
5Y revenue growth
11.42%

Growth

Revenue Growth (5Y)
11.42%
Above sector avg (1.82%)
Revenue (1Y)-1.90%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-153.51%
Below sector avg (-54.47%)
ROIC-101.92%
Net Margin-340.03%
Op. Margin-339.91%

Safety

Debt / Equity
N/A
Current Ratio2.37
Interest Coverage-132.56

Valuation

PE (TTM|NTM)
-0.44 | 7.03
Above sector avg (-1.49)
P/B Ratio0.44
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Revenue grew 11.42% annually over 5 years — strong growth
Negative free cash flow of -9.75 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 13.32%

Price History

Financial Trends

Analyst Price Target

No analyst coverage available

Growth

Rev 5Y: 11.42% · Earnings 1Y: N/A
Revenue Growth (1Y) -1.90% Revenue Growth (3Y) 55.84%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 11.42% Earnings Growth (5Y) N/A

Profitability

ROE: -153.51% · Net Margin: -340.03%
Revenue (TTM) 3.32 M Net Income (TTM) -11.29 M
ROE -153.51% ROA -81.57%
Gross Margin 49.83% Operating Margin -339.91%
Net Margin -340.03% Free Cash Flow (TTM) -9.75 M
ROIC -101.92% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 2.37
Debt / Equity N/A Current Ratio 2.37
Interest Coverage -132.56 Asset Turnover 0.24
Working Capital 7.05 M Tangible Book Value 7.82 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0.44 · EV/EBITDA: N/A
P/E Ratio -0.44 Forward P/E 7.03
P/B Ratio 0.44 P/S Ratio 1.48
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield 14.22%
FCF Yield -198.06%
Market Cap 4.92 M Enterprise Value 4.18 M

Per Share

EPS: -7.09 · FCF/Share: -4.87
EPS (Diluted TTM) -7.09 Revenue / Share 1.66
FCF / Share -4.87 OCF / Share -4.69
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 86.33% · CapEx/Rev: 11.15%
CapEx / Revenue 11.15% FCF Conversion 86.33%
SBC-Adj. FCF -10.04 M Growth Momentum -13.32

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 3.05 M 3.11 M 1.26 M 437,146.0 1.98 M
Net Income -10.57 M -10.16 M -10.63 M -8.31 M -7.04 M
EPS (Diluted) -2.00 -6.38 -10.58 — —
Gross Profit 1.25 M 1.43 M 326,668.0 — —
Operating Income -10.64 M -10.28 M -12.60 M -8.34 M -5.57 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A 970,117.0 974,355.0 814,481.0 — —
Interest Expense 60,890.0 — — — —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8.25 M 13.78 M 10.35 M 12.35 M 21.86 M
Total Liabilities 5.44 M 5.60 M 6.67 M 5.81 M 6.85 M
Shareholders' Equity 3.00 M 8.33 M 3.80 M 6.62 M 15.06 M
Total Debt 1.65 M 1.65 M — — —
Cash & Equivalents 1.02 M 6.30 M 1.54 M 8.24 M 12.57 M
Current Assets 4.14 M 8.53 M 3.86 M 10.87 M 18.21 M
Current Liabilities 5.35 M 5.45 M 5.88 M 4.66 M 3.68 M

Peer Comparison

vs Manufacturing sector median (1605 peers)
Metric Stock Sector Median
P/E -0.4 -1.5
P/B 0.4 1.6
ROE % -153.5 -54.5
Net Margin % -340.0 -41.5
Rev Growth 5Y % 11.4 1.8
D/E — 0.3